Key vendors are developing remote monitoring applications to increase their sales strategically Technavio, a company that develops over 2000 pieces of research every year and covers more than 500 technologies across 80 countries, has announced the top five leading vendors for the global artificial pancreas devices system market in their latest research report. This…
Technavio, a tech-focused market research firm, has published a new report on the global next-generation biologics market, which is expected to experience a steady growth rate with a CAGR of more than 14% during the forecast period 2016-2020. This latest report by Technavio covers the market outlook and growth prospects of the global next-gen…
The global pharmaceutical contract manufacturing market was valued at over $58 billion in 2015 and is expected to surpass $82 billion by 2020, says Technavio. Technavio’s cardiovascular and metabolic disorders portfolio has announced its latest market research report on pharmaceutical contract manufacturing for the forecast period, 2016-2020. This market analysis discusses the major drivers and key emerging…
Technavio, a tech-focused market research firm, has published a new report on the global age-related macular degeneration market, which is expected to experience a slow but steady growth rate with a CAGR of more than 7% during the forecast period. This latest report by Technavio covers the market outlook and growth prospects of the…
According to the latest market research study released by Technavio, the global metabolic disorders therapeutics market is expected to grow at a CAGR of close to 5% during the forecast period 2016-2020. This market research report by Technavio provides an in-depth analysis of the market in terms of revenue and emerging market trends. The…
According to the latest market research study released by Technavio, the global cystic fibrosis therapeutics market is expected to grow at a CAGR of close to 32% during the forecast period 2016-2020. This market research report by Technavio provides an in-depth analysis of the market in terms of revenue and emerging market trends. The…
The global lumbar spine fusion market was valued at $7 billion in 2015 and is expected to surpass $9 billion by 2020, says Technavio. Technavio has announced its latest market research report on lumbar spine fusion to its cardiovascular and metabolic disorders portfolio. This market analysis discusses the major drivers and key emerging trends…
Key vendors shift their focus from biologics to biosimilars Technavio, a company that develops over 2000 pieces of research every year and covers more than 500 technologies across 80 countries, has announced the top five leading vendors for the global gastrointestinal therapeutics market in their latest research report. This report also lists 64 other…
The global mAB biosimilars market was valued at around $391 million in 2015 and is expected to surpass $3,746 million by 2020, says Technavio. Technavio has announced its latest market research report on mAB biosimilars to its cardiovascular and metabolic disorders portfolio. This market analysis discusses the major drivers and key emerging trends that…
Key vendors to increase their sales by introducing regenerative medicine-based biologics Technavio, a company that develops over 2000 pieces of research every year and covers more than 500 technologies across 80 countries, has announced the top five leading vendors for the global musculoskeletal disorder therapeutics market in their latest research report. This report also…
